(Q46817499)

25 December 2017

title

Pioglitazone plus a sulphonylurea or metformin is associated with increased lipoprotein particle size in patients with type 2 diabetes (English)

1 reference

25 December 2017

0 references

1 reference

1 reference

Alfonso Perez

1

1 reference

25 December 2017

Mehmood Khan

series ordinal

2

1 reference

25 December 2017

Todd Johnson

series ordinal

3

1 reference

25 December 2017

Mahinda Karunaratne

series ordinal

4

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

25 December 2017

Diabetes and Vascular Disease Research

published in

1 reference

25 December 2017

volume

1

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

44-50

1 reference

25 December 2017

Peroxisome proliferator-activated receptors: from genes to physiology

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Triglyceride as a risk factor for coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

The role of small, dense low density lipoprotein (LDL): a new look

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Thiazolidinediones and blood lipids in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Effect of Diabetes on Lipoprotein Size

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Unique lipoprotein phenotype and genotype associated with exceptional longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2004.006

21 January 2018

Identifiers

DOI

10.3132/DVDR.2004.006

1 reference

25 December 2017

1 reference

25 December 2017